Bing Xin

4PUBLICATIONS
7CO-AUTHORS
Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 28, 2026
Liver kinase B1 maintains natural killer cell survival by regulating redox homeostasis.

Wanqing Meng, Liang Luo, Zhiqiang Xiao

|May 03, 2022
Pharmaceutical SH2 domain-containing protein tyrosine phosphatase 2 inhibition suppresses primary and metastasized liver tumors by provoking hepatic innate immunity.

Jacey J Liu, Bing Xin, Li Du

|Dec 03, 2021
Enhancing the therapeutic efficacy of programmed death ligand 1 antibody for metastasized liver cancer by overcoming hepatic immunotolerance in mice.

Bing Xin, Meixiang Yang, Panyisha Wu

|Jan 30, 2019
An Efficient Combination Immunotherapy for Primary Liver Cancer by Harmonized Activation of Innate and Adaptive Immunity in Mice.

Liang Wen, Bing Xin, Panyisha Wu

Pageof 1

Frequent Collaborators

1 joint publications

Chuanhui Peng

1 joint publications

Jacey J Liu

1 joint publications

Li Du

1 joint publications

Gen-Sheng Feng